Wait, WHAT?! Russia already approved a COVID-19 vaccine?
Vaccines
Jennifer Beam Dowd, PhD
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
A: Sort of, and not really. In a surprising announcement Tuesday, Russia claimed it had approved the world’s first COVID-19 vaccine, which was only tested in 76 people thus far. Russian President Vladimir Putin endorsed using the vaccine, ambitiously dubbed “Sputnik V,” claiming that his adult daughter had received it. In reality, the Ministry of Read more…
Immunology 101 Video
Biology/Immunity VaccinesJennifer Beam Dowd, PhD
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
Hi Awesome Nerds! As a “booster” to our recent post on vaccine developments, we want to share with you all an amazing 8-minute video on “Immunology 101” made by Prof. Akiko Iwasaki, Professor of Immunobiology at Yale School of Medicine. Watch with your kids, it’s very accessible and the visualizations are great!! Link to original Read more…
VACCINE NEWS UPDATE!
VaccinesLindsey Leininger, PhD MA
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity Vaccines
Jennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
TL;DR: Our well-diversified “stock portfolio” of vaccine candidates is demonstrating strong first-quarter returns. Still too early to predict annual fund performance. More information: A partnership between Oxford and AstraZeneca released data last week indicating that their vaccine candidate is SAFE and SPARKED AN IMMUNE RESPONSE in trial participants. Another team from the Chinese biotech CanSino Read more…
Has the virus really mutated?! Does this make it even MORE infectious or deadly?
Biology/Immunity VaccinesJennifer Beam Dowd, PhD
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
Vaccines
Lindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
A: YES, and NOT NECESSARILY. There is evidence of a genetic change in the virus’ spike protein, with the new variant (G614) becoming dominant in Europe and the U.S. These types of small genetic changes are not unusual, and there are a couple of main reasons why a new variant could become dominant: 1) Natural Read more…
VACCINE NEWS ALERT
VaccinesLindsey Leininger, PhD MA
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe Vaccines
Malia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
TL;DR: Pfizer’s first-round draft pick is doing well at vaccine candidate training camp. Next up: Game time. More information: STUDY DESIGN: Pfizer released data from a small, short-term randomized trial of 45 patients assessing a vaccine candidate’s (1) safety and (2) ability to spark an immune system response. FINDINGS: (1) Safety: Minimal presence of serious Read more…
I heard that the MMR vaccine prevents COVID-19. Should I get an MMR vaccine?
Infection and Spread Staying Safe VaccinesMalia Jones, PhD MPH
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines Videos
Malia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
A: If you haven’t had one already, you should definitely get an MMR vaccine to prevent measles, mumps, and rubella! But no evidence so far supports the idea that your MMR vaccine might prevent COVID-19. We’ve all seen the news: risk of dying of COVID-19 infection jumps at about age 50 and increases every year Read more…
COVID-19 Vaccine Development
Vaccines VideosMalia Jones, PhD MPH
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments Vaccines
Lindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
James H. Conway, MD, FAAP (Infectious disease pediatrician at UW-Madison) chats with Nerdy Girls Malia Jones and Lindsey Leininger about vaccine development and the COVID-19 vaccine progress. Link to original FB post
Any recent news on the treatment/vaccine front?
Treatments VaccinesLindsey Leininger, PhD MA
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity Vaccines
Malia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
A: Yes! Three happy pieces of news this week: (1) The launch of an early-stage clinical trial for what’s believed to be the world’s first antibody treatment against COVID-19; (2) A Stat News interview with Dr. Fauci showcasing his cautious optimism about vaccine development; (3) New data on the anti-viral Remdesivir indicating the treatment’s effectiveness Read more…
I heard you say on the Dear Pandemic NG Live that the new COVID-19 vaccine candidate from Moderna is a new type of vaccine. Can you explain that?
Biology/Immunity VaccinesMalia Jones, PhD MPH
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
Vaccines
Lindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
A: We recently heard reports from the pharmaceutical company Moderna that they had a successful early trial of a vaccine for SARS-CoV-2. The way this vaccine candidate works is completely different from previous vaccines that you have likely had. It’s called an mRNA vaccine. In order to explain this, we’re going to take a deeper Read more…
I hear there’s good news on the vaccine front this week. Can you please provide an overview?
VaccinesLindsey Leininger, PhD MA
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
Vaccines
Lauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
A: A new type of vaccine technology has demonstrated safety and the ability to spark an immune reaction in a small sample of people, providing proof-of-concept for its eventual use as a broadly administered vaccine. Which is indeed good news. But alas, it’s still very early days….. A little bit of background: The new technology Read more…
How do you make a vaccine and what progress have we made in developing a vaccine for Covid-19?
VaccinesLauren Hale, PhD MA
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines Videos
Malia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
Vaccines are complicated! Thank you to the virologists, lab technicians, and support teams currently developing a vaccine. A recent article in Nature offers a nice visual and tutorial on vaccines. Here is the condensed version. Roughly 90 SARS-CoV-2 (novel coronavirus) vaccines are being developed and tested. Each one works to prevent the virus from causing Read more…
Nerdy Girls Live 4/20/20
Infection and Spread Staying Safe Testing and Contact Tracing Vaccines VideosMalia Jones, PhD MPH
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
Vaccines
Lindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
COVID-19 issues like daycare, herd immunity, vaccines, social circles, testing, and more are addressed by Dear Pandemic Nerdy Girls Malia Jones, PhD, MPH, Dr. Lindsey Leininger, PhD, Dr. Jenn Dowd, PhD, and Amanda M. Simanek, PhD, MPH. From Dear Pandemic FB Live Q&A on 4/20/20. Link to original FB post
Phase I Vaccine Trial Launching in Seattle
VaccinesLindsey Leininger, PhD MA
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
News out of the NIH: a Phase I vaccine clinical trial is launching in Seattle. Impressively speedy time-to-launch. Interested in learning more about clinical trials? Here’s a comprehensive, non-technical resource. Link to original FB post
